BR112018000242A2 - composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico - Google Patents
composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóicoInfo
- Publication number
- BR112018000242A2 BR112018000242A2 BR112018000242A BR112018000242A BR112018000242A2 BR 112018000242 A2 BR112018000242 A2 BR 112018000242A2 BR 112018000242 A BR112018000242 A BR 112018000242A BR 112018000242 A BR112018000242 A BR 112018000242A BR 112018000242 A2 BR112018000242 A2 BR 112018000242A2
- Authority
- BR
- Brazil
- Prior art keywords
- kcal
- sphingomyelin
- doco
- compositions containing
- nutritional compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 title abstract 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- 235000019197 fats Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000007472 neurodevelopment Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/184—Emulsifier
- A23V2250/1848—Phosphatidyl Ethanolamine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1862—Arachidonic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/18—Lipids
- A23V2250/186—Fatty acids
- A23V2250/1868—Docosahexaenoic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
- A23V2250/54248—Lactoferrin
Abstract
a presente invenção refere-se a uma composição e um método para a promoção do desenvolvimento neuronal funcional em pacientes pediátricos. a composição compreende em algumas modalidades até cerca de 7 g/100 kcal de uma fonte de gordura ou lipídeo; até cerca de 5 g/100 kcal de uma fonte de proteína; cerca de 3 mg/100 kcal a cerca de 50 mg/100 kcal de fosfatidiletanolamina; cerca de 0,15 mg/100 kcal a cerca de 75 mg/100 kcal de esfingomielina; e cerca de 5 mg/100 kcal a cerca de 75 mg/100 kcal de ácido docosaexaenóico. os métodos compreendem, em algumas modalidades, a administração da composição anteriormente mencionada a um paciente pediátrico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/796,372 US10617701B2 (en) | 2015-07-10 | 2015-07-10 | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid |
PCT/US2016/037218 WO2017011117A1 (en) | 2015-07-10 | 2016-06-13 | Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018000242A2 true BR112018000242A2 (pt) | 2018-09-04 |
Family
ID=56297105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018000242A BR112018000242A2 (pt) | 2015-07-10 | 2016-06-13 | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico |
Country Status (12)
Country | Link |
---|---|
US (1) | US10617701B2 (pt) |
EP (1) | EP3319462A1 (pt) |
CN (1) | CN107920574A (pt) |
AR (1) | AR105237A1 (pt) |
AU (1) | AU2016294169A1 (pt) |
BR (1) | BR112018000242A2 (pt) |
CA (1) | CA2991935A1 (pt) |
HK (1) | HK1252651A1 (pt) |
MX (1) | MX2018000143A (pt) |
PH (1) | PH12018500036A1 (pt) |
TW (1) | TW201711574A (pt) |
WO (1) | WO2017011117A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10034937B2 (en) | 2015-12-04 | 2018-07-31 | Mead Johnson Nutrition Company | Synergistic nutritional compositions and uses thereof |
US20180168215A1 (en) * | 2016-12-21 | 2018-06-21 | Mead Johnson Nutrition Company | Nutritional compositions containing inositol and uses thereof |
EP3618645A1 (en) * | 2017-05-03 | 2020-03-11 | Société des Produits Nestlé S.A. | Whey protein extracts and their use as sphingomyelin source |
WO2019090093A1 (en) * | 2017-11-03 | 2019-05-09 | Advanced Bionutrition Corp. | Composition containing viable microorganisms and methods of making |
US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
US20210113623A1 (en) * | 2018-06-22 | 2021-04-22 | Fonterra Co-Operative Group Limited | Use of polar lipids to treat or prevent gestational diabetes mellitus |
BR112021008377A2 (pt) * | 2018-12-13 | 2021-08-03 | Société des Produits Nestlé S.A. | concentrados líquidos formulados para diluição em produtos nutricionais para promover a deglutição segura para indivíduos com disfagia |
WO2023232462A1 (en) * | 2022-05-31 | 2023-12-07 | Mjn U.S. Holdings Llc | Use of milk fat globule membrane in synthetic infant nutrition |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1177863B (it) | 1984-07-03 | 1987-08-26 | Fidia Farmaceutici | Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche |
IE61701B1 (en) | 1986-07-17 | 1994-11-30 | Morinaga Milk Industry Co Ltd | Process for producing bovine lactoferrin in high purity |
IN172427B (pt) | 1989-11-14 | 1993-07-24 | Fidia Spa | |
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
DK165090D0 (da) | 1990-07-09 | 1990-07-09 | Kem En Tec As | Konglomererede partikler |
ES2033193B1 (es) | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
EP1092352A3 (en) | 1991-01-24 | 2003-08-27 | Martek Corporation | Microbial oil mixtures and uses thereof |
US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
FR2714574B1 (fr) | 1993-12-31 | 1996-03-15 | Inst Rech Biolog Sa | Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants. |
NZ330484A (en) | 1994-02-16 | 1999-11-29 | Pharming Bv | Isolation of lactoferrin especially recombinant lactoferrin from milk |
US5686491A (en) | 1994-09-14 | 1997-11-11 | Sigma-Tau Pharmaceuticals, Inc. | Infant formula |
SE9503926D0 (sv) | 1995-11-07 | 1995-11-07 | Pharmacia Biotech Ab | Adsorptionsförfarande och separationsmedium |
WO1999065586A2 (en) | 1998-06-18 | 1999-12-23 | Upfront Chromatography A/S | Expanded bed adsorption system |
US6475984B2 (en) | 1999-04-29 | 2002-11-05 | The Nemours Foundation | Administration of leptin |
JP4339979B2 (ja) | 2000-02-28 | 2009-10-07 | 雪印乳業株式会社 | 葉酸及び/又はビタミンb12−ラクトフェリン類複合物 |
AU2001258238B2 (en) | 2000-05-12 | 2005-06-23 | Upfront Chromatography A/S | A bed adsorption system |
US6332533B1 (en) | 2000-08-29 | 2001-12-25 | H.H.H. Incorprorated | Media holder mouse pad |
NZ530152A (en) | 2001-06-01 | 2005-07-29 | Upfront Chromatography As | Fractionation of protein containing mixtures |
EP1480524B1 (en) | 2002-03-07 | 2013-04-17 | Upfront Chromatography A/S | A process of isolating lactoferrin |
DE10226367A1 (de) | 2002-06-13 | 2003-12-24 | Nutricia Nv | Ganglioside mit modifizierter Acylfunktion |
US7951410B2 (en) | 2003-04-14 | 2011-05-31 | Mead Johnson Nutrition Company | Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid |
CA2530437C (en) * | 2003-06-23 | 2011-11-15 | Nestec S.A. | Nutritional formula for optimal gut barrier function |
WO2006064778A1 (ja) | 2004-12-13 | 2006-06-22 | Oji Paper Co., Ltd. | 感熱記録体 |
US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
EA017195B1 (ru) | 2005-11-04 | 2012-10-30 | Арла Фудз Амба | Концентрат, полученный из молочного продукта, обогащенный природно встречающейся сиалиллактозой, и способ его получения |
US20080003330A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Infant formulas for early brain development |
US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
CN101902918A (zh) * | 2007-10-19 | 2010-12-01 | 方塔拉合作集团有限公司 | 保持或增加成长或认知发育的方法 |
EP2251031A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and neuronal health and development in the infant gut |
EP2251030A1 (en) | 2009-05-12 | 2010-11-17 | Nestec S.A. | Lactoferrin and brain health and development in infants |
EP2258218A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
EP2258216A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
EP2258217A1 (en) | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Children |
US20120219526A1 (en) * | 2009-10-29 | 2012-08-30 | Nestec S.A. | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof |
WO2011069987A1 (en) | 2009-12-08 | 2011-06-16 | Nestec S.A. | Infant formula with probiotics and milk fat globule membrane components |
WO2011115476A1 (en) | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
US20110293784A1 (en) | 2010-05-28 | 2011-12-01 | Anja Wittke | Milk-based nutritional compositions |
US8968722B2 (en) | 2010-12-29 | 2015-03-03 | Mead Johnson Nutrition Company | Milk-based nutritional compositions containing lactoferrin and uses thereof |
PT2594282E (pt) | 2011-11-21 | 2014-09-26 | Nestec Sa | Lactoferrina e a matéria branca |
EP2609814A1 (en) * | 2011-12-30 | 2013-07-03 | Nestec S.A. | Lactobacillus reuteri DSM 17938 for the development of cognitive function |
US20140199265A1 (en) * | 2013-01-11 | 2014-07-17 | Mead Johnson Nutrition Company | Nutritional compositions containing a neurologic component and uses thereof |
US9226914B2 (en) | 2013-07-16 | 2016-01-05 | Mead Johnson Nutrition Company | Methods for promoting neuronal development and/or health |
US9609888B2 (en) | 2013-07-31 | 2017-04-04 | Mead Johnson Nutrition Company | Nutritional compositions containing synergistic combination and uses thereof |
CN105792675A (zh) | 2013-12-12 | 2016-07-20 | 雀巢产品技术援助有限公司 | 用于促进男性和女性婴儿及儿童认知功能的健康建立的包含多不饱和脂肪酸类(pufa)的合成乳组合物 |
-
2015
- 2015-07-10 US US14/796,372 patent/US10617701B2/en active Active
-
2016
- 2016-06-13 AU AU2016294169A patent/AU2016294169A1/en not_active Abandoned
- 2016-06-13 EP EP16734092.6A patent/EP3319462A1/en not_active Withdrawn
- 2016-06-13 CA CA2991935A patent/CA2991935A1/en not_active Abandoned
- 2016-06-13 CN CN201680040625.8A patent/CN107920574A/zh active Pending
- 2016-06-13 WO PCT/US2016/037218 patent/WO2017011117A1/en active Application Filing
- 2016-06-13 MX MX2018000143A patent/MX2018000143A/es unknown
- 2016-06-13 BR BR112018000242A patent/BR112018000242A2/pt not_active Application Discontinuation
- 2016-06-23 TW TW105119760A patent/TW201711574A/zh unknown
- 2016-07-01 AR ARP160102005A patent/AR105237A1/es unknown
-
2018
- 2018-01-04 PH PH12018500036A patent/PH12018500036A1/en unknown
- 2018-09-18 HK HK18111958.7A patent/HK1252651A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AR105237A1 (es) | 2017-09-20 |
AU2016294169A1 (en) | 2018-01-04 |
PH12018500036A1 (en) | 2018-07-09 |
WO2017011117A1 (en) | 2017-01-19 |
TW201711574A (zh) | 2017-04-01 |
EP3319462A1 (en) | 2018-05-16 |
MX2018000143A (es) | 2018-06-19 |
CN107920574A (zh) | 2018-04-17 |
CA2991935A1 (en) | 2017-01-19 |
US10617701B2 (en) | 2020-04-14 |
US20170007629A1 (en) | 2017-01-12 |
HK1252651A1 (zh) | 2019-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018000242A2 (pt) | composições nutricionais contendo fosfatidiletanolamina, esfingomielina e ácido doco-saexaenóico | |
PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
BR112018000236A2 (pt) | composições nutricionais e métodos para a promoção do desenvolvimento cognitivo | |
BR112014032905A2 (pt) | métodos de redução do risco de um evento cardiovascular em um sujeito em terapia com estatina | |
BR112018072064B8 (pt) | Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação | |
BR112014008511A2 (pt) | composições nutricionais com fitonutrientes | |
BR112015001884A2 (pt) | composição nutricional para promover a saúde musculoesquelética em pacientes com doença inflamatória intestinal (ibd) | |
EA201070419A1 (ru) | Состав для регулирования метаболизма липидов | |
BR112013010556A2 (pt) | métodos e composições adequadas para a promoção de uma pele saudável | |
PH12017502181A1 (en) | Nutritional compositions containing an elevated level of inositol and uses thereof | |
BR112015029897A2 (pt) | composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição | |
BR112016015660A2 (pt) | formulação farmacêutica de neuregulina (nrg) e formulação farmacêutica liofilizada de neuregulina (nrg) | |
BR112019003410A2 (pt) | composições e métodos para modulação da microflora gastrointestinal em um canino | |
BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
BR112017000312A2 (pt) | sistema de tratamento da saúde bucal para a aplicação de fosfato de cálcio amorfo, uso de um ou mais aminoácidos básicos, composição, e uso de um ou mais aminoácidos em um sistema de tratamento da saúde bucal | |
BR112017006416A2 (pt) | composição nutricional para meio gastrointestinal para proporcionar perfil aperfeiçoado de microbioma e metabólico | |
PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
BR112014019399A2 (pt) | métodos de tratamento da fibrose | |
BR112015027631A2 (pt) | Métodos para melhorar perfis de lipídeo usando atrasentana | |
BR112015006656A8 (pt) | composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos | |
UY37611A (es) | Formulaciones de evolocumab de alta concentración y baja viscosidad y métodos para elaborarlas | |
BR112018008040A2 (pt) | composição nutricional compreendendo um hidrolisado de caseína, bem como um butirato dietético e/ou um composto para estimular a formação de butirato endógeno | |
BR112016025481A2 (pt) | alimentos, sistemas, métodos e estojos para provisão de substituição de eletrólito | |
BR112015031416A2 (pt) | métodos para a promoção do desenvolvimento e/ou da saúde neuronal compreendendo a administração de uma combinação de ácido docosa-hexaenoico e ácido alfa-lipoico | |
BR112017015613A2 (pt) | gel intestinal de levodopa e carbidopa e métodos de utilização |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |